Get the Stockscreener App
20.79
1.42%
-0.30
After Hours:
20.39
-0.40
-1.92%
Vera Therapeutics Inc stock is traded at $20.79, with a volume of 1.67M.
It is down -1.42% in the last 24 hours and down -11.76% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$21.09
Open:
$20.85
24h Volume:
1.67M
Relative Volume:
1.01
Market Cap:
$1.33B
Revenue:
-
Net Income/Loss:
$-107.85M
P/E Ratio:
-9.4072
EPS:
-2.21
Net Cash Flow:
$-106.82M
1W Performance:
-4.98%
1M Performance:
-11.76%
6M Performance:
-44.23%
1Y Performance:
-43.18%
1-Day Range:
$20.30
$21.14
1-Week Range:
$20.30
$21.93
52-Week Range:
$18.53
$51.61
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
20.79 | 1.34B | 0 | -107.85M | -106.82M | -2.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-05-25 | Resumed | H.C. Wainwright | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Jan-28-25 | Initiated | Goldman | Buy |
| Nov-21-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Published on: 2025-07-30 16:01:27 - metal.it
Can Vera Therapeutics Inc. stock recover from recent declineWeekly Hot Picks With Buy Confidence Released - beatles.ru
What are the technical indicators suggesting about Vera Therapeutics Inc.Swing Trade Forecasts For Smart Trading - jammulinksnews.com
Why is Vera Therapeutics Inc. stock attracting strong analyst attentionSwing Trade Report To Watch Now - jammulinksnews.com
How volatile is Vera Therapeutics Inc. stock compared to the marketAchieve breakthrough gains with expert advice - jammulinksnews.com
What are Vera Therapeutics Inc. company’s key revenue driversInvest confidently with data-backed picks - jammulinksnews.com
What are analysts’ price targets for Vera Therapeutics Inc. in the next 12 monthsCapitalize on market trends before they peak - jammulinksnews.com
Is Vera Therapeutics Inc. a growth stock or a value stockGet professional advice for portfolio optimization - jammulinksnews.com
What catalysts could drive Vera Therapeutics Inc. stock higher in 2025Unlock daily market insights for better trades - jammulinksnews.com
Does Vera Therapeutics Inc. stock perform well during market downturnsAccess high-yield investment alerts now - jammulinksnews.com
Will Vera Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Stock Investment Discussion Area - metal.it
Behind The Volatility Of Vera Therapeutics (NASDAQ:VERA) - Seeking Alpha
Vera Therapeutics Reports Positive Phase 3 ORIGIN Trial Results for Atacicept in IgA Nephropathy - MSN
Vera Therapeutics Inc. Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
Does Vera Therapeutics Inc. stock pay reliable dividendsRapid market gains - jammulinksnews.com
Why Vera Therapeutics Inc. stock is on top investor watchlistsRemarkable growth - jammulinksnews.com
What analysts say about Vera Therapeutics Inc. stockLightning-fast capital gains - Autocar Professional
What drives Vera Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Is Vera Therapeutics Inc. a good long term investmentUnstoppable trading performance - jammulinksnews.com
Polycythemia Vera Pipeline 2025: Latest FDA Approvals, - openPR.com
Fund Remains in Vera Therapeutics Short-Swing Trading Lawsuit - Bloomberg Law News
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):